MV

Marikandathil Velayudhan Gireeshnadh

Director Additional Director DIN 09633591
DIN 09633591 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Marikandathil Velayudhan Gireeshnadh

Data last updated:

Marikandathil Velayudhan Gireeshnadh was an Additional Director at Arecia Lifesciences Private Limited (2022). The company operates in Pharma.

DIN 09633591
Primary Designation Additional Director
Industry Pharma
First Appointment 28 May 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arecia Lifesciences Private Limited U74999KL2018PTC054923
Additional Director28 May 20222018₹25.7 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arecia Lifesciences Private Limited
Premium access

Shareholding and investment profile for Marikandathil Velayudhan Gireeshnadh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Marikandathil Velayudhan Gireeshnadh

Marikandathil Velayudhan Gireeshnadh was first appointed on 28 May 2022 as Additional Director at Arecia Lifesciences Private Limited.

Marikandathil Velayudhan Gireeshnadh held 1 earlier board appointment: Arecia Lifesciences Private Limited (Additional Director, 28 May 2022 to 05 Sep 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available